SCHEMBL23867468

SCHEMBL23867468

Cc1cc(Nc2ccc(NC(=O)Cc3c[nH]c4ccc(O)cc34)cc2)nc(N2CCCC2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.45
▸ LMNA P02545 6/20 0.44
▸ MAPT P10636 4/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 2/20 0.43
▸ SLC2A1 P11166 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ HCRTR1 O43613 2/20 0.43
▸ HCRTR2 O43614 2/20 0.43
▸ ROCK2 O75116 3/20 0.43
▸ GLA P06280 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ PMP22 Q01453 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867470 0.91 HRH3 (0.44) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867472 0.90 HRH3 (0.48) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867473 0.89 HCRTR1 (0.53) HPGDSLC2A1KDM4EHCRTR1HCRTR2
SCHEMBL30234700 0.85 HRH3 (0.47) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867524 0.83 HCRTR1 (0.52) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL30979651 0.82 SLC2A1 (0.51) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL31094227 0.81 SLC2A1 (0.44) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL31094238 0.77 SLC2A1 (0.50) LMNAMAPTALDH1A1HPGDSLC2A1
SCHEMBL23859943 0.77 HRH3 (0.53) HRH3LMNAMAPTALDH1A1HPGD
SCHEMBL30165658 0.77 HRH3 (0.53) HRH3LMNAMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback